Evidence map›Paper›PMID 41712062›Full record

ReviewActa parasitologica2026

The Fight is not Over: Sustained Vigilance Against Schistosomiasis Needing in China.

Haoran Zhong, Yamei Jin, Jiaojiao Lin

Abstract readReview
PubMed Publisher
In one paragraph

Review in Acta parasitologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Haoran ZhongNational Reference Laboratory for Animal Schistosomiasis, Key Laboratory of Animal Parasitology of Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, People's Republic of China.
Yamei JinNational Reference Laboratory for Animal Schistosomiasis, Key Laboratory of Animal Parasitology of Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, People's Republic of China. yameijin@shvri.ac.cn.
Jiaojiao LinNational Reference Laboratory for Animal Schistosomiasis, Key Laboratory of Animal Parasitology of Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, People's Republic of China. jjlin@shvri.ac.cn.

Funding

Agricultural Science and Technology Innovation Program CAAS-ASTIP-2025-SHVRIShanghai Sailing Program 24YF2756800
6 · The paper itself

Abstract

China has achieved remarkable progress toward eliminating schistosomiasis, yet potential risks persist due to residual snail habitats, animal reservoirs, and uneven surveillance coverage. This paper synthesizes current surveillance frameworks and recent literature to identify key challenges and propose actionable directions for sustaining elimination achievements. It emphasizes the need to distinguish serological evidence of past exposure from active infection when interpreting surveillance results. To consolidate elimination outcomes, we recommend a phased, evidence-based strategy: (1) strengthen integrated human–animal–environment surveillance systems, (2) enhance data sharing and cross-sectoral coordination under the One Health framework, and (3) develop long-term mechanisms for resource allocation and emergency response in re-emergence areas. These recommendations aim to guide policy refinement and prioritize resource investment for sustainable schistosomiasis control in the post-elimination era.

Indexed as

Disease EradicationEpidemiological MonitoringSchistosomiasisAnimalsChinaDisease ReservoirsHumansSnailsIntegrated preventionOncomelania hupensisOne healthSchistosoma japonicumSurveillance

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.